R-Tech Ueno: Announcement On Collaborative Development Of Therapeutic Agent For Diabetic Retinopathy And Diabetic Macular Edema Utilizing VAP-1 Inhibitor (RTU-1096) With Hokkaido University


R-Tech Ueno, Ltd. has announced plans to conduct collaborative research with a group led by Professor Susumu Ishida and Associate Professor Kousuke Noda of the Department of Ophthalmology, Graduate School of Medicine from Hokkaido University. The research is in the application of a new VAP-1 inhibitor (Development Code: RTU-1096), which is under our development for treatment of diabetic retinopathy (DR) and diabetic macular edema.

Help employers find you! Check out all the jobs and post your resume.

Back to news